GlymaxX enables a boost of antibody-dependent cell-mediated cytotoxicity (ADCC)... Mar 18
NKMax America has developed a proprietary NK cell expansion and activation technology platform which allows it to produce unprecedented commercial amounts of autologous and allogeneic ... Oct 20
The survival rate is also relatively higher than other tumour types when having appropriate treatment... Oct 09
Breakthrough Innovation in Cancer Care From Merck Pipeline to Be Presented at ASCO 2020 ... May 14
New subgroup analyses for first-line treatment of advanced renal cell carcinoma with BAVENCIO®* (avelumab) in combination with axitinib... Sep 23
-Advertisements-